Effect of Biliopancreatic Diversion on Glucose Homeostasis
BPD-Mingrone
1 other identifier
interventional
24
1 country
1
Brief Summary
Biliopancreatic diversion (BPD) surgery results in greater resolution of type 2 diabetes than all other bariatric surgical procedures, and it is hypothesized that this procedure has specific beneficial effects on glucose homeostasis beyond weight loss alone. The BPD procedure is performed in more than 150 patients/year by surgeons at the Division of Obesity and Metabolic Disorders, Catholic University of the Sacred Heart, School of Medicine, in Rome, Italy. The purpose of this study is to provide a better understanding of the effect of the BPD bariatric surgical procedure on insulin action and pancreatic beta cell function. It is hypothesized that weight loss achieved with BPD surgery will have greater effects on insulin sensitivity and beta cell function than weight loss induced by Roux-en-Y gastric bypass (RYGB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2016
CompletedFirst Submitted
Initial submission to the registry
March 13, 2017
CompletedFirst Posted
Study publicly available on registry
April 13, 2017
CompletedApril 13, 2017
April 1, 2017
2.5 years
March 13, 2017
April 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in skeletal muscle insulin sensitivity will be assessed using the Hyperinsulinemic-Euglycemic Clamp (HEC) procedure, before and after weight loss induced by either BPD or RYGB surgery
Insulin sensitivity: The HEC procedure will be used to evaluate insulin sensitivity before and after 20% weight loss induced by either BPD or RYGB surgery
Change from Baseline up to a possible 9 months
Study Arms (2)
RYGB
ACTIVE COMPARATORSubjects received Roux-en-Y Gastric Bypass surgery.
BPD
EXPERIMENTALSubjects received Biliopancreatic Diversion Surgery
Interventions
In Roux-en-Y Gastric Bypass Surgery a small gastric pouch is created and connected to a segment of jejunum. Bowel continuity is restored by reconnecting the "Roux" limb and the biliopancreatic limb approximately \~75-150 cm distal to the gastrojejunostomy. Therefore, ingested food bypasses most of the stomach, the entire duodenum, and a short segment of the jejunum.
In Biliopancreatic Diversion Surgery a horizontal gastrectomy is conducted leaving a portion of the stomach, which is connected to the small intestine, \~250 cm from the ileocecal valve and the biliopancreatic limb is connected to the ileum, \~50 cm from the ileocecal valve. Digestive secretions from the biliopancreatic limb mix in the common channel, where ingested food is also delivered by the alimentary limb.
Eligibility Criteria
You may qualify if:
- Body Mass Index (BMI) ≥ 35 kg/m²
- Undergoing either the RYGB or the BPD procedure.
- Able to provide informed consent to participate in the research study
You may not qualify if:
- Weight \> 450 pounds
- Smoke \> 7 cigarettes per day
- Previous malabsorptive or restrictive intestinal surgery
- Pregnant or breastfeeding
- Inflammatory intestinal disease
- Diabetes
- Unstable dose of medications in the last 4 weeks before the pre-surgery metabolic studies
- Severe organ dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic University of the Sacred Heart
Rome, 00128, Italy
Related Publications (2)
Angelini G, Salinari S, Castagneto-Gissey L, Bertuzzi A, Casella-Mariolo J, Ahlin S, Boskoski I, Gaggini M, Raffaelli M, Costamagna G, Casella G, Marini PL, Gastaldelli A, Bornstein S, Mingrone G. Small intestinal metabolism is central to whole-body insulin resistance. Gut. 2021 Jun;70(6):1098-1109. doi: 10.1136/gutjnl-2020-322073. Epub 2020 Sep 29.
PMID: 32994312DERIVEDHarris LA, Kayser BD, Cefalo C, Marini L, Watrous JD, Ding J, Jain M, McDonald JG, Thompson BM, Fabbrini E, Eagon JC, Patterson BW, Mittendorfer B, Mingrone G, Klein S. Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass. Cell Metab. 2019 Nov 5;30(5):855-864.e3. doi: 10.1016/j.cmet.2019.09.002. Epub 2019 Oct 3.
PMID: 31588013DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel Klein, MD
Washington University School of Medicine
- PRINCIPAL INVESTIGATOR
Geltrude Mingrone, MD, PhD
Catholic University of the Sacred Heart
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2017
First Posted
April 13, 2017
Study Start
January 9, 2014
Primary Completion
June 28, 2016
Study Completion
June 28, 2016
Last Updated
April 13, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share